Literature DB >> 15320745

Retracted: Effects of Vitamin K2 on Osteoporosis

Jun Iwamoto1, Tsuyoshi Takeda1, Yoshihiro Sato2.   

Abstract

The article entitled “Effects of Vitamin K2 on Osteoporosis, published in Curr Pharm Des 2004; 10(21): 2557-76, by Iwamoto J, Takeda T and Sato Y.” has been retracted by the Editorial office of the journal Current Pharmaceutical Design, as the text, data and some figures used/referred in this review article are from sources which have been retracted or under investigation on the basis of data fabrication and falsification, authorship misconduct, duplicate publication, unethical research practices, text recycling/self-plagiarism, and unresolved concerns about data integrity and research conduct. The authors were informed of this complaint and were requested to give justification on the matter in their defense. However, no reply was received from their side in this regard. Some sources that have been retracted are as follows: REFERENCE: 1. Iwamoto J, Takeda T, Ichimura S. Combined treatment with vitamin K2 and bisphosphonate in postmenopausal women with osteoporosis. Yonsei Med J 2003; 44: 751-6. Available at: https://eymj.org/DOIx.php?id=10.3349/ymj.2019.60.1.115. 2. Sato Y, Honda Y, Kuno H, Oizumi K. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. Bone 1998; 23: 291-6. Available at: https://www.sciencedirect.com/science/article/pii/S8756328298001082. 3. Sato Y, Honda Y, Kaji M, Asoh T, Hosokawa K, Kondo I, et al. Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency. Bone 2002; 31: 114-8. Available at: https://pubmed.ncbi.nlm.nih.gov/ 12110423/. Bentham Science apologizes to its readers for any inconvenience this may have caused. The Bentham Editorial Policy on Article. Retraction can be found at https://benthamscience.com/editorial-policies-main.php BENTHAM SCIENCE DISCLAIMER: It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript, the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15320745     DOI: 10.2174/1381612043383782

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  17 in total

1.  Urinary levels of cross-linked N-terminal telopeptide of type I collagen and nutritional status in Japanese professional baseball players.

Authors:  Jun Iwamoto; Tsuyoshi Takeda; Kazuhiro Uenishi; Hiromi Ishida; Yoshihiro Sato; Hideo Matsumoto
Journal:  J Bone Miner Metab       Date:  2010-02-18       Impact factor: 2.626

2.  Effect of hyperlipidemia on femoral biomechanics and morphology in low-density lipoprotein receptor gene knockout mice.

Authors:  Evelise Aline Soares; Wilson Romero Nakagaki; José Antonio Dias Garcia; José Angelo Camilli
Journal:  J Bone Miner Metab       Date:  2012-01-14       Impact factor: 2.626

3.  ENA Actimineral Resource A restores bone loss and bone quality in ovariectomized rats.

Authors:  Sun Hee Do; Sung-Yong Hwa; Won-Il Jeong; Ji-Won Lee; Hyun-Jung Kim; In-Seon Lee; Kyu-Shik Jeong
Journal:  Mol Cell Biochem       Date:  2006-07-13       Impact factor: 3.396

4.  Effect of 1-year dietary supplementation with vitaminized olive oil on markers of bone turnover and oxidative stress in healthy post-menopausal women.

Authors:  Laura Mazzanti; Maurizio Battino; Laura Nanetti; Francesca Raffaelli; Alessandro Alidori; Giulia Sforza; Flavia Carle; Veronica Quagliarini; Nelvio Cester; Arianna Vignini
Journal:  Endocrine       Date:  2015-01-20       Impact factor: 3.633

5.  High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam.

Authors:  Marcos D Machado-Fragua; Emiel O Hoogendijk; Ellen A Struijk; Fernando Rodriguez-Artalejo; Esther Lopez-Garcia; Joline W Beulens; Adriana J van Ballegooijen
Journal:  Eur J Nutr       Date:  2019-05-08       Impact factor: 5.614

6.  Induction of apoptosis in PA-1 ovarian cancer cells by vitamin K2 is associated with an increase in the level of TR3/Nur77 and its accumulation in mitochondria and nuclei.

Authors:  Toshiko Sibayama-Imazu; Yukari Fujisawa; Yutaka Masuda; Toshihiro Aiuchi; Shigeo Nakajo; Hiroyuki Itabe; Kazuyasu Nakaya
Journal:  J Cancer Res Clin Oncol       Date:  2008-01-17       Impact factor: 4.553

Review 7.  Prevention and treatment of corticosteroid-induced osteoporosis.

Authors:  Jun Iwamoto; Tsuyoshi Takeda; Yoshihiro Sato
Journal:  Yonsei Med J       Date:  2005-08-31       Impact factor: 2.759

8.  Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women.

Authors:  M H J Knapen; L J Schurgers; C Vermeer
Journal:  Osteoporos Int       Date:  2007-02-08       Impact factor: 4.507

9.  Strategy for prevention of hip fractures in patients with Parkinson's disease.

Authors:  Jun Iwamoto; Yoshihiro Sato; Tsuyoshi Takeda; Hideo Matsumoto
Journal:  World J Orthop       Date:  2012-09-18

10.  Association between atherosclerosis and osteoporosis, the role of vitamin D.

Authors:  Olivera Ilić Stojanovic; Milica Lazovic; Marko Lazovic; Marina Vuceljic
Journal:  Arch Med Sci       Date:  2011-05-17       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.